FGF2 and prostate cancer: In this context, Pecqueux et al., demonstrated the correlation existing between the high expression of bFGF in the tumor stroma and a high rate of postoperative relapse [185]; moreover, exogenous bFGF is capable of modulating genomic instability, thus promoting the progression of prostate cancer by increasing DNA damage [186].